Nasr N Alrabadi

20PUBLICATIONS
40CO-AUTHORS
NanomaterialsInnate immunityBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 26, 2026
In Vitro Evaluation of Novel Nano-Sized Colloidal Assemblies Incorporating Hydrophobic Tobramycin Ion Pairs: Enhanced Cellular Uptake with Preserved Antimicrobial Activity Toward Oral Drug Delivery.

|Mar 06, 2026
One-year seropositivity after COVID-19 infection: A study from a developing country.

Nasr Alrabadi, Haneen Obeidat, Razan Haddad

|Mar 20, 2024
Sex differences in clinical features, utilization of oral anticoagulant agents, and 1-year outcome in Middle Eastern patients with atrial fibrillation.

Nasr Alrabadi, Mohammed Al-Nusair, Razan Haddad

|Mar 13, 2024
The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis.

Obada Ababneh, Alina Ghazou, Mohmmad Alawajneh

|May 01, 2023
Validation of CHA2DS2 VASc Score Predictability of Stroke and Systemic Embolization in a Middle Eastern Population with AF: The Jordan Atrial Fibrillation (JoFib) Study.

Rasheed Ibdah, Omar Obeidat, Yousef Khader

|Jul 27, 2022
Development of Self-Emulsifying Drug Delivery Systems (SEDDSs) Displaying Enhanced Permeation of the Intestinal Mucus Following Sustained Release of Prototype Thiol-Based Mucolytic Agent Load.

Ahmad Malkawi, Nasr Alrabadi, Razan Haddad

Pageof 4

Frequent Collaborators

7 joint publications

Karem H Alzoubi

4 joint publications

Ayman Hammoudeh

3 joint publications

Razan Haddad

2 joint publications

Rasheed K Ibdah